Table 1.
Genetic and clinical description of ALG6-CDG patients published from 1998 to 2011
Reported ALG6-CDG patients | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
---|---|---|---|---|---|---|---|---|---|---|
ALG6 gene mutation | c.998C>T (Homozygous and heterozygous) | Paternal: c.924C>A and c.391T>C, Maternal: c.998C>T (Heterozygous) | c.895-897 delATA and c.IVS3 + G>A (Heterozygous) | IVS 3 + 5G>A and c.998C>T or c.680G>A (Heterozygous) | c.509G>T and 1330_1332delCTT (Heterozygous) | c.391T>C and c.998C>T (Heterozygous) or c.391TT>C (Homozygous) | IVS3 + 3_3insT and c.998C>T (Heterozygous) | IVS7 + 2T>G and 897-897-899delAAT (Heterozygous) | c.338G>A and 10–12 Mb del(1)(p31.2p32.3) (Heterozygous) | c.482A>G (Homozygous) |
Amino acid change | p.A333V(or combined with other mutation) | p.S308A, p.Y131H and p.A333V | In-frame deletion (delI299) and in-frame skipping | Aberrant splicing and p.A333V or p.G227E | p.S170I and in-frame deletion (ΔL444) | p.Y131H and p.A333V or p.Y131H alone | In-frame skipping and p.A333V | Aberrant splicing and in-frame deletion (delI299) | p.R113H and a deletion described on gDNA level | p.Y161C |
Neurological abnormalities | ||||||||||
Microcephaly/macrocephaly | Not reported | – | – | + (microcephaly) | Not reported | – | – | – | + (macrocephaly) | – |
Hypotonia | + | + | + | + | + | + | + | + | + | + |
Strabismus (internal or external if mentioned) | + (internal) | Not reported | + | + | – | + | + | – | + | – |
Psychomotor retardation (including speech delay) | + | + | + | + | + (normal speech development) | + | + | + | + | + |
Epilepsy | + | + | – | + | + | + | + | + | Not reported | + |
Hypokinesia/ tremors | −/+ | – | – | – | – | – | + (tremors) | + (tremors) | – | + (hypokinesia) |
EEG | Mostly normal | Normal | Abnormal | Not reported | Not reported | Normal | Not reported | Not reported | Normal | Not reported |
Brain imaging | Cortical atrophy | Delayed myelination, slight cortical atrophy | Thin corpus callosum, mild cerebellar atrophy , mild widening of CSF spaces and ventricular system | Minimal cortical atrophy | – | Agenesis of corpus callosum (Westphal et al. 2003), cerebellar dysfunction (Miller et al. 2011) | Delayed myelination, normal cerebellum | Papilledema, but MRI normalized with age | Hypoplastic corpus callosum and absent septum pellucidum, white matter abnormality | Widening of CSF spaces and ventricular system, normal cerebellum |
Optic dysfunction and/or -atrophy | −/+ | + | + | + | + | + (Miller et al. 2011) | Not reported | + | – | + |
Dysmorphism | Broad nasal bridge, prominent forehead and large ears | – | – | Anormal long and narrow distal limbs, inverted nipples (noted at 6.5 months) | – | Broad nasal bridge | – | Abnormal fingers and toes (distal phalangeal hypoplasia with shortened toes and fingers) | Facial and limb abnormalities, deep set eyes, broad nasal bridge, loose skin, unusual fat distribution and other dysmorphic features | Severe body and facial abnormalities, inverted nipples and broad nasal bridge |
Gastrointestinal symptoms | – | Severe protein-losing enteropathy, gastroenteritis and diarrhea | – | Protein-losing enteropathy | – | Gastrointestinal disturbances | Peripheral edema and diarrhea, abdominal distention, protein-losing enteropathy | – | Mild hepatomegaly | – |
Other symptoms | Poor feeding, recurrent infections | Hormonal abnormalities, e.g., cortisol deficiency | – | Poor feeding, apnea at the age of 4.5 months | – | Abnormal endocrinological function | Poor feeding (anorexia), vomiting, cardiac abnormalities, recurrent infection | Apnea, cyanosis, abnormal hair growth and distribution, ovaria and hormonal abnormalities | Poor feeding, cardiac abnormality: biventricular hypertrophy | Poor feeding, cardiomyopathy, brachycephaly, bilateral cryptorchidism, bilateral esotropia |
Reference | Imbach et al. 1999 (Genotype) and Grünewald et al. 2000 (Phenotype), Körner et al. 1998 | Westpal et al. 2000 (Dec) | Hanefeld et al. 2000 (Phenotype) and Westphal et al. 2000a (Genotype) | Imbach et al. 2000 (genotype), Du Plessis et al. 2001 (phenotype) and Schollen et al. 2002 | De Lonlay et al. 2001 | Westphal et al. 2003 and Miller et al. 2011 | Newell et al. 2003 | Sun et al. 2005 | Eklund et al. 2006 | Al-Qwaine et al. 2010 |
– : Not present
+ : Present (severity not indicated)